Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,196 | -118,081 | -70,161 | -220,662 | -193,056 |
| Depreciation Amortization | 7,183 | 4,645 | 2,277 | 7,716 | 5,639 |
| Income taxes - deferred | 884 | 871 | 487 | -185 | -326 |
| Accounts receivable | -32,727 | -26,726 | -14,335 | N/A | N/A |
| Accounts payable and accrued liabilities | 8,816 | 3,395 | 1,862 | 1,590 | 1,259 |
| Other Working Capital | -52,972 | -40,620 | -17,699 | -23,655 | -20,669 |
| Other Operating Activity | 49,767 | 28,170 | 22,004 | 28,925 | 38,816 |
| Operating Cash Flow | $-216,245 | $-148,346 | $-75,565 | $-206,271 | $-168,337 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 99,932 | 51,888 | -51,304 | -359,733 | N/A |
| PPE Investments | -19,928 | -15,520 | -8,243 | -22,075 | -10,963 |
| Purchase Sale Intangibles | -8,089 | N/A | N/A | -12,744 | N/A |
| Other Investing Activity | -8,089 | 0 | 0 | -12,744 | 0 |
| Investing Cash Flow | $71,915 | $36,368 | $-59,547 | $-394,552 | $-10,963 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 550,579 | 550,572 |
| Other Financing Activity | -2,542 | -768 | 0 | 38,975 | 8,975 |
| Financing Cash Flow | $-2,542 | $-768 | $N/A | $589,554 | $559,547 |
| Exchange Rate Effect | 5,690 | 9,273 | 3,558 | -261 | 37,955 |
| Beginning Cash Position | 228,804 | 228,805 | 228,805 | 240,335 | 240,335 |
| End Cash Position | 87,622 | 125,332 | 97,251 | 228,805 | 658,537 |
| Net Cash Flow | $-141,182 | $-103,473 | $-131,554 | $-11,530 | $418,202 |
| Free Cash Flow | |||||
| Operating Cash Flow | -216,245 | -148,346 | -75,565 | -206,271 | -168,337 |
| Capital Expenditure | -19,928 | -15,520 | -8,243 | -22,075 | -10,963 |
| Free Cash Flow | -236,173 | -163,866 | -83,808 | -228,346 | -179,300 |